[Distribution of 111In-oxine labeled lymphocytes in adoptive immunotherapy of hepatoma].
Shiomi
S
S
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007205:Indium Radioisotopes; D007261:Infusions, Intra-Arterial; D007275:Injections, Intravenous; D007376:Interleukin-2 / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000378:metabolism* / Q000637:transplantation; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000031:analogs & derivatives
D007205:Indium Radioisotopes; D007376:Interleukin-2; D009942:Organometallic Compounds; C032950:indium oxine; D015125:Oxyquinoline